162 related articles for article (PubMed ID: 29541540)
1. Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma.
Jahr G; Broi MD; Holte H; Beiske K; Meling TR
Brain Behav; 2018 Mar; 8(3):e00928. PubMed ID: 29541540
[TBL] [Abstract][Full Text] [Related]
2. A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
Liu CJ; Lin SY; Yang CF; Yeh CM; Kuan AS; Wang HY; Tsai CK; Gau JP; Hsiao LT; Chen PM; Liu YC; Hong YC; Ko PS; Liu JH; Lin CH
Cancer Med; 2020 Mar; 9(6):2134-2145. PubMed ID: 32011103
[TBL] [Abstract][Full Text] [Related]
3. A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups.
Gao Y; Wei L; Kim SJ; Wang L; He Y; Zheng Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Theresa PK; Deutsch A; Zhan H; Lai J; Wang Y; You H
Front Oncol; 2021; 11():696147. PubMed ID: 34422649
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the Nordic and the MSKCC chemotherapy protocols on the overall and progression-free survival in intracranial PCNSL.
Da Broi M; Jahr G; Beiske K; Holte H; Meling TR
Blood Cells Mol Dis; 2018 Nov; 73():25-32. PubMed ID: 30217760
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
[TBL] [Abstract][Full Text] [Related]
6. The role of surgery in intracranial PCNSL.
Jahr G; Da Broi M; Holte H; Beiske K; Meling TR
Neurosurg Rev; 2018 Oct; 41(4):1037-1044. PubMed ID: 29383600
[TBL] [Abstract][Full Text] [Related]
7. Demographics, Pattern of Care & Outcomes of Primary CNS Lymphoma- Experience from a Tertiary Care Cancer Center in India.
Das S; Bagal B; Jain H; Kashyap L; Anbarasan S; Abhishek S; Bondili S; Nayak L; Thorat J; Mirgh S; Gokarn A; Punatar S; Ayushi S; Epari S; Tembhare P; Shetty P; Khanna N; Goda J; Aliasgar M; Gupta T; Sengar M; Khattry N; Laskar S; Menon H
Indian J Hematol Blood Transfus; 2023 Jan; 39(1):57-70. PubMed ID: 36699441
[TBL] [Abstract][Full Text] [Related]
8. Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients.
Zeremski V; Adolph L; Beer S; Berisha M; Jacobs B; Kahl C; Koenecke C; Kropf S; Panse J; Petersen J; Schmidt-Hieber M; Schneider J; Vucinic V; Walter J; Weigert O; Witte HM; Mougiakakos D
Eur J Haematol; 2024 Apr; 112(4):641-649. PubMed ID: 38164819
[TBL] [Abstract][Full Text] [Related]
9. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.
Abrey LE; Ben-Porat L; Panageas KS; Yahalom J; Berkey B; Curran W; Schultz C; Leibel S; Nelson D; Mehta M; DeAngelis LM
J Clin Oncol; 2006 Dec; 24(36):5711-5. PubMed ID: 17116938
[TBL] [Abstract][Full Text] [Related]
10. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience.
Ferreri AJ; Blay JY; Reni M; Pasini F; Spina M; Ambrosetti A; Calderoni A; Rossi A; Vavassori V; Conconi A; Devizzi L; Berger F; Ponzoni M; Borisch B; Tinguely M; Cerati M; Milani M; Orvieto E; Sanchez J; Chevreau C; Dell'Oro S; Zucca E; Cavalli F
J Clin Oncol; 2003 Jan; 21(2):266-72. PubMed ID: 12525518
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase-to-lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single-center study of 223 patients.
Zuo J; Lei T; Zhong S; Zhou J; Liu R; Wu C; Li S
Neurosurg Rev; 2023 Dec; 47(1):17. PubMed ID: 38112846
[TBL] [Abstract][Full Text] [Related]
12. Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma.
Sun X; Wang C; Chen C; Huang J; Wu X; Wang Y; He X; Cao J; Jiang W; Sun P; Li Z
Hematol Oncol; 2021 Dec; 39(5):625-638. PubMed ID: 34543472
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system lymphoma: a profile of 26 cases from Western India.
Agarwal PA; Menon S; Smruti BK; Singhal BS
Neurol India; 2009; 57(6):756-63. PubMed ID: 20139505
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of POD18 combined with improved IELSG in primary central nervous system lymphoma.
Du KX; Shen HR; Pan BH; Luthuli S; Wang L; Liang JH; Li Y; Yin H; Li JY; Wu JZ; Xu W
Clin Transl Oncol; 2024 Mar; 26(3):720-731. PubMed ID: 37558851
[TBL] [Abstract][Full Text] [Related]
15. Evidence of time-dependent prognostic factors predicting early death but not long-term outcome in primary CNS lymphoma: a study of 91 patients.
Ghesquières H; Drouet Y; Sunyach MP; Sebban C; Chassagne-Clement C; Jouanneau E; Honnorat J; Biron P; Blay JY
Hematol Oncol; 2013 Jun; 31(2):57-64. PubMed ID: 22886543
[TBL] [Abstract][Full Text] [Related]
16. A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study.
Wei L; Gao Y; Prochazka KT; Liu R; Wang L; Liu B; He Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Deutsch AJ; Zhan H; Lai J; Kim SJ; You H
J Neurooncol; 2023 Jun; 163(2):301-311. PubMed ID: 37231231
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial.
Joerger M; Huitema AD; Krähenbühl S; Schellens JH; Cerny T; Reni M; Zucca E; Cavalli F; Ferreri AJ
Br J Cancer; 2010 Feb; 102(4):673-7. PubMed ID: 20125159
[TBL] [Abstract][Full Text] [Related]
18. Is deep brain involvement in intracranial primary central nervous system lymphoma of importance for penetration of chemotherapeutic agents?
Meling TR; Latysheva A; Da Broi M; Jahr G; Holte H; Beiske K; Emblem KE
Neuroradiology; 2018 Jul; 60(7):703-713. PubMed ID: 29804159
[TBL] [Abstract][Full Text] [Related]
19. Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).
Abla O; Weitzman S; Blay JY; O'Neill BP; Abrey LE; Neuwelt E; Doolittle ND; Baehring J; Pradhan K; Martin SE; Guerrera M; Shah S; Ghesquieres H; Silver M; Betensky RA; Batchelor T
Clin Cancer Res; 2011 Jan; 17(2):346-52. PubMed ID: 21224370
[TBL] [Abstract][Full Text] [Related]
20. Proposed new prognostic model using the systemic immune-inflammation index for primary central nervous system lymphoma: A prospective-retrospective multicohort analysis.
Li S; Xia Z; Cao J; Zhang J; Chen B; Chen T; Zhang X; Zhu W; Li D; Hua W; Mao Y
Front Immunol; 2022; 13():1039862. PubMed ID: 36439151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
